Variable | VHA Patients | BSWH Patients | HFHS Patients | ||||||
---|---|---|---|---|---|---|---|---|---|
Model 1a HR (95% CI) | Model 2b HR (95% CI) | Model 3c HR (95% CI) | Model 1a HR (95% CI) | Model 2b HR (95% CI) | Model 3c HR (95% CI) | Model 1a HR (95% CI) | Model 2b HR (95% CI) | Model 3c HR (95% CI) | |
Opioid duration | |||||||||
1 to 30 d | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] |
31 to 90 d | 1.23 (1.16–1.31) | 1.20 (1.13–1.28) | 1.18 (1.10–1.25) | 1.22 (0.97–1.52) | 1.31 (1.05–1.65) | 1.29 (1.03–1.62) | 1.39 (1.22–1.59) | 1.33 (1.16–1.52) | 1.33 (1.16–1.52) |
>90 d | 1.31 (1.22–1.40) | 1.39 (1.30–1.48) | 1.35 (1.26–1.44) | 2.26 (1.63–3.14) | 2.04 (1.38–3.02) | 1.88 (1.27–2.78) | 1.90 (1.62–2.24) | 2.19 (1.87–2.56) | 2.05 (1.75–2.40) |
Arthritis | … | … | 1.18 (1.12–1.25) | … | … | 1.35 (1.17–1.56) | … | … | 1.36 (1.22–1.51) |
Back pain | … | … | 1.48 (1.41–1.56) | … | … | 1.43 (1.27–1.61) | … | … | 1.43 (1.31–1.57) |
Headache | … | … | 1.59 (1.52–1.67) | … | … | 1.95 (1.73–2.20) | … | … | 1.52 (1.41–1.65) |
Musculoskeletal pain | … | … | 1.32 (1.26–1.39) | … | … | 0.76 (0.66–0.88) | … | … | 1.24 (1.11–1.38) |
Neuropathy | … | … | 1.12 (1.07–1.17) | … | … | 1.41 (1.21–1.63) | … | … | 1.32 (1.20–1.44) |
Pain score | … | … | 1.24 (1.22–1.26) | … | … | … | … | … | … |